Yacong An
No.8 Xishiku Street, Xicheng District
Beijing, 100034, China
Beijing, 100034, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Therapeutic siRNA: Mechanisms, challenges, strategies, and clinical translation.
Journal: Chinese medical journal
Published: December 29, 2025
Targeted drug delivery to AML by OFA/iLRP aptamer guided DNA nanostructure.
Journal: Scientific reports
Published: June 06, 2025
Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine.
Journal: Journal of cancer research and clinical oncology
Published: January 31, 2023
Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles.
Journal: Molecules (Basel, Switzerland)
Published: January 27, 2023
Novel Complex of PD-L1 Aptamer and Albumin Enhances Antitumor Efficacy In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: February 03, 2022
Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo.
Journal: Molecules (Basel, Switzerland)
Published: January 06, 2021
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
Journal: International journal of nanomedicine
Published: November 26, 2019
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells.
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells.
Journal: Scientific reports
Published: January 22, 2019
Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting.
Journal: Molecules (Basel, Switzerland)
Published: January 09, 2019
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
Journal: Oncotarget
Published: August 18, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026